TY - JOUR
KW - intranasal
KW - naloxone - opioid overdose - pharmacokinetics
KW - Narcan(R) Nasal Spray
AU - P. Krieter
AU - N. Chiang
AU - S. Gyaw
AU - P. Skolnick
AU - R. Crystal
AU - F. Keegan
AU - J. Aker
AU - M. Beck
AU - J. Harris
A1 - 
BT - Journal of clinical pharmacology
C5 - Opioids & Substance Use
DO - 10.1002/jcph.759
JF - Journal of clinical pharmacology
PY - 2016
SN - 1552-4604; 0091-2700
T1 - Pharmacokinetic Properties and Human Use Characteristics of an FDA Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose
T2 - Journal of clinical pharmacology
TI - Pharmacokinetic Properties and Human Use Characteristics of an FDA Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose
U1 - Opioids & Substance Use
U2 - 27145977
U3 - 10.1002/jcph.759
VO - 1552-4604; 0091-2700
Y1 - 2016
ER -